Legal notice

Host

The host of this internet website is the Boehringer Ingelheim Fonds, Stiftung für medizinische Grundlagenforschung, to be rendered in English as "Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine" and abbreviated as BIF.

Address

Boehringer Ingelheim Fonds
Stiftung für medizinische Grundlagenforschung
Schusterstr. 46-48
55116 Mainz
Germany

tel. +49 (0) 6131 / 27 50 8-0

Email: secretariat(at)bifonds.de
homepage: www.bifonds.de

The Boehringer Ingelheim Fonds, a public foundation subject to German civil law and approved by the District Government of Rhineland-Palatinate, Germany, on February 1983, is an independent, not-for-profit institution dedicated to the promotion of basic research in medicine. The Boehringer Ingelheim Fonds is registered in Ingelheim am Rhein, Germany, and is listed in the foundation register of the Rhinelande-Palatinate (https://addinter.service24.rlp.de/cgi-bin-inter/stiftung1.mbr/start).

Representatives and Organs of the Boehringer Ingelheim FondsBoard of Trustees

The Board of Trustees decides on all matters of fundamental significance of the Boehringer Ingelheim Fonds. Its current members are:

  • Prof. Dr Dr Thomas Braun, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (Deputy Chairman)
  • Prof. Michael Häusser, PhD, University College London, UK
  • Prof. Dr Christian Klämbt, University of Münster, Germany
  • Dr Ingrid Ohlert, Deutsche Forschungsgemeinschaft, Bonn, Germany (permanent guest)
  • Dr Dr Michel Pairet, Member of the Shareholders' Committee, C.H. Boehringer Sohn AG & Co. KG, Ingelheim, Germany
  • Prof. Dr Jan-Michael Peters, Research Institute of Molecular Pathology, Vienna, Austria (Chairman)
  • Prof. Marina Rodnina, Max Planck Institute for Multidisciplinary Natural Sciences, Göttingen, Germany
  • Prof. Dr Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, USA.

Executive Committee

The Boehringer Ingelheim Fonds is represented in legal and non-legal matters by at least two members of the Executive Committee. The current members of the Executive Committee are:

  • Prof. Dr  Dr Thomas Braun (Deputy Chairman)
  • Dr Dr Michel Pairet 
  • Prof. Dr Jan-Michael Peters (Chairman).

Managing Directors

The Managing Directors run the regular business of the Boehringer Ingelheim Fonds.

  • Dr Stephan Formella
  • Marc Wittstock

Responsible for content

Dr Stephan Formella and Marc Wittstock

Editor

Kirsten Achenbach

Programming

Optimy, Brussels

Disclaimer

The information published on this website www.bifonds.de has been carefully reviewed and compiled. Nevertheless, mistakes and misunderstandings cannot be ruled out, and the Boehringer Ingelheim Fonds makes no claim or warranties as to the accuracy or completeness of its content and can assume no liability arising therefrom. All services provided without charge are not binding. The Boehringer Ingelheim Fonds reserves the right to amend, supplement or delete information or to stop publication of this website at any time and without notice. The Boehringer Ingelheim Fonds accepts no responsibility for the content of external websites accessed via a link. Published links are carefully reviewed and compiled and are provided to you only as a convenience. The editorial staff of Boehringer Ingelheim Fonds has no influence on the current and future design and content of linked websites. The Boehringer Ingelheim Fonds is not responsible for the content of linked websites and does not adopt that content as its own. The provider of the website to which published links lead is solely responsible for any illegal, erroneous or incomplete content and for any losses or damages arising out of the use or non-use of that information. No liability will be accepted by the party which merely refers to such a website via a link.

Copyright

All content on this website is the property of the Boehringer Ingelheim Fonds and is protected by copyright unless indicated otherwise. ©Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine, Mainz, Germany.

Full or partial reproduction for educational, scientific, or personal purposes only is permitted, provided that the source is acknowledged (unless otherwise specified). Commercial use requires prior consent by the Boehringer Ingelheim Fonds. Permission given above does not include the use of the design or layout of the www.bifonds.de website. No graphic, photo, logo, or image from this website may be copied or retransmitted unless expressly permitted by the Boehringer Ingelheim Fonds. Any rights not expressly granted herein are reserved.

Home